8-K/A: Current report (Amendment)
Apr 19 07:54 ET
10-K: Annual report
Apr 16 16:16 ET
Ayala Pharmaceuticals | S-8 POS: S-8 POS
Apr 15 16:40 ET
Ayala Pharmaceuticals | S-8 POS: S-8 POS
Apr 15 16:40 ET
Ayala Pharmaceuticals | S-8 POS: S-8 POS
Apr 15 16:36 ET
Ayala Pharmaceuticals | S-8 POS: S-8 POS
Apr 15 16:36 ET
Ayala Pharmaceuticals | S-8 POS: S-8 POS
Apr 15 16:35 ET
Ayala Pharmaceuticals | S-8 POS: S-8 POS
Apr 15 16:35 ET
Ayala Pharmaceuticals | S-8 POS: S-8 POS
Apr 15 16:35 ET
Ayala Pharmaceuticals | S-8 POS: S-8 POS
Apr 15 16:35 ET
Ayala Pharmaceuticals | S-8 POS: S-8 POS
Apr 15 16:35 ET
Ayala Pharmaceuticals | 8-K: Current report
Apr 3 17:04 ET
Ayala Pharmaceuticals | NT 10-K: Others
Apr 1 16:34 ET
Ayala Pharmaceuticals | 8-K: Current report
Mar 29 17:08 ET
Ayala Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Israel Biotech Fund I, L.P.
Mar 6 07:18 ET
Ayala Pharmaceuticals | 8-K: Current report
Mar 5 16:38 ET
Ayala Pharmaceuticals | DEFM14C: Others
Mar 5 08:17 ET
Ayala Pharmaceuticals | 8-K: Current report
Feb 23 16:40 ET
Ayala Pharmaceuticals | PREM14C: Others
Feb 20 17:27 ET
Ayala Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Redmile Group, LLC(1.9%),Jeremy C. Green(1.9%)
Feb 14 16:28 ET
No Data
No Data